A Biotech Set to Dominate the Next 20 Years

A Biotech Set to Dominate the Next 20 Years

Source: 
Motley Fool
snippet: 

Investing in growth stocks can feel like a roller-coaster ride. For instance, at the beginning of the year, Ionis Pharmaceuticals (NASDAQ:IONS) was trading at $52 a share. By April, the stock was up to $86 a share. And now it's back down to $59. That's a fair amount of volatility! Individual stocks can and do move up and down, sometimes as much as 10% (or more) in a day -- but it's probably a bad idea to follow the market so closely. As long as the company's numbers continue to rise and impress, its stock price will do the same. So let's take a look at what's important at Ionis.